Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases

Bibliographic Details
Title: Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases
Authors: Chunsu Liang, Pengjiao An, Yizhou Zhang, Xin Liu, Bo Zhang
Source: Frontiers in Immunology, Vol 15 (2024)
Publisher Information: Frontiers Media S.A., 2024.
Publication Year: 2024
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: drug reaction with eosinophilia and systemic symptoms, drug-induced hypersensitivity syndrome, FDA adverse event reporting system, fatal cases, drug adverse reaction, systematic review, Immunologic diseases. Allergy, RC581-607
More Details: BackgroundDrug rash with eosinophilia and systemic symptoms (DRESS) is a life-threatening severe cutaneous adverse reaction.ObjectiveThis study aims to study fatal DRESS cases using FAERS database and systematic review.MethodsData of the FDA Adverse Event Reporting System (FAERS) database were extracted and manipulated. Articles from Pubmed, Embase and CINAHL databases were screened.Results0.13% of the adverse events submitted to FAERS was identified as DRESS and the percentage of fatal cases was up to 6.62%. The top five drugs calculated to induce DRESS with the highest number of reported cases were allopurinol, lamotrigine, vancomycin, amoxicillin and carbamazepine. The top five drugs statistically related to fatal outcome with the highest number of reported cases were allopurinol, vancomycin, trimethoprim, sulfamethoxazole and lamotrigine. Skin manifestations remained the main reason for admission and the average time from dose to rash onset was 27.19 days. The most commonly cited culprit medication type were antibiotics (50.00%), anti-gout agents (15.38%) and anti-epileptic drug (11.54%).ConclusionsWe discussed fatal cases of DRESS through FAERS system and case reports, hoping to raise awareness when using relevant drugs.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1490334/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2024.1490334
Access URL: https://doaj.org/article/f44d43cc7c94458db57345c6bcb73507
Accession Number: edsdoj.f44d43cc7c94458db57345c6bcb73507
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2024.1490334
Published in:Frontiers in Immunology
Language:English